Chiara Zanato

Dr. Chiara Zanato

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2018 in Nature
Verified
Journal Article
Open access
PDF file
MSMark H. T. Stappers
Mark H. T. Stappers
ACAlexandra E. Clark
Alexandra E. Clark
VAVishukumar AIMANIANDA
Vishukumar AIMANIANDA
SBStefan Bidula
Stefan Bidula
DRDelyth M. Reid
Delyth M. Reid
GBGordon D. Brown
Gordon D. Brown
Resistance to infection is critically dependent on the ability of pattern recognition receptors to recognize microbial invasion and induce protective immune responses. One such family of receptors are the C-type lectins, which are central to antifungal immunity1. These receptors activate key effector mechanisms upon recognition of conserved fungal cell-wall carbohydrates. However, several other immunologically active fungal ligands have been described; these include melanin2,3, for which the mechanism of recognition is hitherto undefined. Here we identify a C-type lectin receptor, melanin-sensing C-type lectin receptor (MelLec), that has an essential role in antifungal immunity through recognition of the naphthalene-diol unit of 1,8-dihydroxynaphthalene (DHN)-melanin. MelLec recognizes melanin in conidial spores of Aspergillus fumigatus as well as in other DHN-melanized fungi. MelLec is ubiquitously expressed by CD31+ endothelial cells in mice, and is also expressed by a sub-population of these cells that co-express epithelial cell adhesion molecule and are detected only in the lung and the liver. In mouse models, MelLec was required for protection against disseminated infection with A. fumigatus. In humans, MelLec is also expressed by myeloid cells, and we identified a single nucleotide polymorphism of this receptor that negatively affected myeloid inflammatory responses and significantly increased the susceptibility of stem-cell transplant recipients to disseminated Aspergillus infections. MelLec therefore recognizes an immunologically active component commonly found on fungi and has an essential role in protective antifungal immunity in both mice and humans.

8 June 2015 in Neuropsychopharmacology
Verified
Journal Article
Closed access
BIBogna M Ignatowska-Jankowska
Bogna M Ignatowska-Jankowska
GBGemma L Baillie
Gemma L Baillie
SKSteven Kinsey
Steven Kinsey
MCMolly Crowe
Molly Crowe
SGSudeshna Ghosh
Sudeshna Ghosh
RRRuth A Ross
Ruth A Ross

3 May 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CTChih-Chung Tseng
Chih-Chung Tseng
GBGemma Baillie
Gemma Baillie
GDGiulia Donvito
Giulia Donvito
MMMohammed A. Mustafa
Mohammed A. Mustafa
SJSophie E. Juola
Sophie E. Juola
IGIain R. Greig
Iain R. Greig

1 March 2018 in Pharmacological Research
Verified
Journal Article
Closed access
JMJose Mitjavila
Jose Mitjavila
DYDanielle Yin
Danielle Yin
PKPushkar M. Kulkarni
Pushkar M. Kulkarni
CZChiara Zanato
Chiara Zanato
GTGanesh A. Thakur
Ganesh A. Thakur
ASAlex Straiker
Alex Straiker

23 September 2015 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
STSara Tommasi
Sara Tommasi
CZChiara Zanato
Chiara Zanato
BLBenjamin Lewis
Benjamin Lewis
Pramod NairPramod Nair
Pramod Nair
SDSergio Dall'Angelo
Sergio Dall'Angelo
Arduino MangoniArduino Mangoni
Arduino Mangoni
Dimethylarginine dimethylaminohydrolase (DDAH) is a key enzyme involved in the metabolism of asymmetric dimethylarginine (ADMA) and N-monomethyl arginine (NMMA), which are endogenous inhibitors of the nitric oxide synthase (NOS) family of enzymes. Two isoforms of DDAH have been identified in humans, DDAH-1 and DDAH-2. DDAH-1 inhibition represents a promising strategy to limit the overproduction of NO in pathological states without affecting the homeostatic role of this important messenger molecule. Here we describe the design and synthesis of 12 novel DDAH-1 inhibitors and report their derived kinetic parameters, IC50 and Ki. Arginine analogue 10a, characterized by an acylsulfonamide isosteric replacement of the carboxylate, showed a 13-fold greater inhibitory potential relative to the known DDAH-1 inhibitor, L-257. Compound 10a was utilized to study the putative binding interactions of human DDAH-1 inhibition using molecular dynamics simulations. The latter suggests that several stabilizing interactions occur in the DDAH-1 active-site, providing structural insights for the enhanced inhibitory potential demonstrated by in vitro inhibition studies.

8 December 2023 in Science Advances
Verified
Journal Article
Open access
DZDongxu Zhai
Dongxu Zhai
SYShuxin Yan
Shuxin Yan
JSJames Samsom
James Samsom
LWLe Wang
Le Wang
PSPing Su
Ping Su
FLFang Liu
Fang Liu
While most research and treatments for multiple sclerosis (MS) focus on autoimmune reactions causing demyelination, it is possible that neurodegeneration precedes the autoimmune response. Hence, glutamate receptor antagonists preventing excitotoxicity showed promise in MS animal models, though blocking glutamate signaling prevents critical neuronal functions. This study reports the discovery of a small molecule that prevents AMPA-mediated excitotoxicity by targeting an allosteric binding site. A machine learning approach was used to screen for small molecules targeting the AMPA receptor GluA2 subunit. The lead candidate has potent effects in restoring neurological function and myelination while reducing the immune response in experimental autoimmune encephalitis and cuprizone MS mouse models without affecting basal neurotransmission or learning and memory. These findings facilitate development of a treatment for MS with a different mechanism of action than current immune modulatory drugs and avoids important off-target effects of glutamate receptor antagonists. This class of MS therapeutics could be useful as an alternative or complementary treatment to existing therapies.